UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Rheometric Scientific, Inc.
------------------------------
(Name of Issuer)
Common Stock, $.01 par value per share
----------------------------------------
(Title of Class of Securities)
762073104
--------------------
(CUSIP Number)
Andlinger Capital XXVI
105 Harbor Drive
Stamford, CT 06902
Attention: Stephen A. Magida
(203) 348-6690
with a copy to:
Paul Gluck, Esq.
Dechert
30 Rockefeller Plaza
New York, NY 10112 (212)
(212) 698-3533
------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
November 20, 2000
--------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box .
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
---------------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
CUSIP NO. 762073104
---------- ---------------------------------------------------------------------
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Andlinger Capital XXVI LLC
--------- ----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X]
--------- ----------------------------------------------------------------------
3 SEC USE ONLY
--------- --------- ------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------- ----------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT [ ]
5 TO ITEMS 2(d) or 2(E)
--------- ---------------------------------------------------------------------
CITIZENSHIP OR PLACE OR ORGANIZATION
6
Delaware
--------- ----------------------------------------------------------------------
----------------------- --------- ----------------------------------------------
Number of SOLE VOTING POWER
Shares
Beneficially 0 shares
owned by 7
each
reporting
person with --------- ----------------------------------------------
8 SHARED VOTING POWER
16,606,000 shares
--------- ----------------------------------------------
9 SOLE DISPOSITIVE POWER
0
--------- ----------------------------------------------
10 SHARED DISPOSITIVE POWER
16,606,000 shares
----------------------- --------- ----------------------------------------------
------------ -------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,606,000 shares
------------ -------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
------------ -------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
59.5%
------------ -------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
00
------------ -------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 762073104
--------- ----------------------------------------------------------------------
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Gerhard R. Andlinger
--------- --------- ------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X]
--------- --------- ------------------------------------------------------------
3 SEC USE ONLY
--------- --------- ------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
--------- --------- ------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT [ ]
5 TO ITEMS 2(d) or 2(E)
--------- --------- ------------------------------------------------------------
CITIZENSHIP OR PLACE OR ORGANIZATION
6
United States of America
--------- ----------------------------------------------------------------------
----------------------- --------- ----------------------------------------------
Number of SOLE VOTING POWER
Shares
Beneficially 0 shares
owned by 7
each
reporting
person with
--------- ----------------------------------------------
8 SHARED VOTING POWER
16,606,000 shares
--------- ----------------------------------------------
9 SOLE DISPOSITIVE POWER
0 shares
--------- ----------------------------------------------
10 SHARED DISPOSITIVE POWER
16,606,000 shares
----------------------- --------- ----------------------------------------------
------------ -------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,606,000 shares
------------ -------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
------------ -------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
59.5%
------------ -------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
IN
------------ -------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 762073104
--------- ----------------------------------------------------------------------
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
--------- Robert M. Castello
--------- ------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X]
--------- --------- ------------------------------------------------------------
3 SEC USE ONLY
--------- --------- ------------------------------------------------------------
4 SOURCE OF FUNDS*
00
--------- --------- ------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT [ ]
TO ITEMS 2(d) or 2(E)
--------- ----------------------------------------------------------------------
CITIZENSHIP OR PLACE OR ORGANIZATION
6
United States of America
--------- ----------------------------------------------------------------------
----------------------- --------- ----------------------------------------------
Number of SOLE VOTING POWER
Shares
Beneficially 0 shares
owned by 7
each
reporting
person with
--------- ----------------------------------------------
8 SHARED VOTING POWER
16,606,000 shares
--------- ----------------------------------------------
9 SOLE DISPOSITIVE POWER
0 shares
--------- ----------------------------------------------
10 SHARED DISPOSITIVE POWER
16,606,000 shares
----------------------- --------- ----------------------------------------------
------------ -------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,606,000 shares
------------ -------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES * [ ]
------------ -------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
59.5%
------------ -------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
IN
------------ -------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 762073104
--------- ----------------------------------------------------------------------
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Stephen A. Magida
--------- --------- ------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X]
--------- --------- ------------------------------------------------------------
3 SEC USE ONLY
--------- --------- ------------------------------------------------------------
4 SOURCE OF FUNDS*
00
--------- --------- ------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT [ ]
TO ITEMS 2(d) or 2(E)
--------- --------- ------------------------------------------------------------
CITIZENSHIP OR PLACE OR ORGANIZATION
6
United States of America
--------- ----------------------------------------------------------------------
----------------------- --------- ----------------------------------------------
Number of SOLE VOTING POWER
Shares
Beneficially 0 shares
owned by 7
each
reporting
person with
--------- ----------------------------------------------
8 SHARED VOTING POWER
16,606,000 shares
--------- ----------------------------------------------
9 SOLE DISPOSITIVE POWER
0 shares
--------- ----------------------------------------------
10 SHARED DISPOSITIVE POWER
16,606,000 shares
----------------------- --------- ----------------------------------------------
------------ -------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,606,000 shares
------------ -------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
------------ -------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
59.5%
------------ -------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
IN
------------ -------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 762073104
--------- ----------------------------------------------------------------------
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Mark F. Callaghan
----------------------------------------------------------------------
--------- ----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X]
--------- --------- ------------------------------------------------------------
3 SEC USE ONLY
--------- --------- ------------------------------------------------------------
4 SOURCE OF FUNDS*
00
--------- --------- ------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT [ ]
TO ITEMS 2(d) or 2(E)
--------- --------- ------------------------------------------------------------
CITIZENSHIP OR PLACE OR ORGANIZATION
6
United States of America
--------- ----------------------------------------------------------------------
----------------------- --------- ----------------------------------------------
Number of SOLE VOTING POWER
Shares
Beneficially 0 shares
owned by 7
each
reporting
person with
--------- ----------------------------------------------
8 SHARED VOTING POWER
16,606,000 shares
--------- ----------------------------------------------
9 SOLE DISPOSITIVE POWER
0 shares
--------- ----------------------------------------------
10 SHARED DISPOSITIVE POWER
16,606,000 shares
----------------------- --------- ----------------------------------------------
------------ -------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,606,000 shares
------------ -------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
------------ -------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
59.5%
------------ -------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
IN
------------ -------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 762073104
--------- ----------------------------------------------------------------------
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Merrick G. Andlinger
--------- ----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X]
--------- --------- ------------------------------------------------------------
3 SEC USE ONLY
--------- --------- ------------------------------------------------------------
4 SOURCE OF FUNDS*
00
--------- --------- ------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT [ ]
TO ITEMS 2(d) or 2(E)
--------- --------- ------------------------------------------------------------
CITIZENSHIP OR PLACE OR ORGANIZATION
6
United States of America
--------- ----------------------------------------------------------------------
----------------------- --------- ----------------------------------------------
Number of SOLE VOTING POWER
Shares
Beneficially 0 shares
owned by 7
each
reporting
person with
--------- ----------------------------------------------
8 SHARED VOTING POWER
16,606,000 shares
--------- ----------------------------------------------
9 SOLE DISPOSITIVE POWER
0 shares
--------- ----------------------------------------------
10 SHARED DISPOSITIVE POWER
16,606,000 shares
----------------------- --------- ----------------------------------------------
------------ -------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,606,000 shares
------------ -------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
------------ -------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
59.5%
------------ -------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
IN
------------ -------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Item 1. Security and Issuer.
-------------------
This Amendment No. 1 to Statement on Schedule 13D (this "Amendment")
amends and supplements the Statement on Schedule 13D filed with the Securities
and Exchange Commission on March 17, 2000 (the "Original Statement" and, as
amended by this Amendment, the "Statement") on behalf of Andlinger Capital XXVI
LLC ("Andlinger Capital XXVI") Gerhard R. Andlinger, Robert M. Castello, Stephen
A. Magida, Merrick G. Andlinger and Mark F. Callaghan (collectively, the
"Reporting Persons"), relates to the common stock, $.01 par value per share (the
"Common Stock"), of Rheometric Scientific, Inc., a Delaware corporation (the
"Issuer"), and is being filed pursuant to Rule 13d-1 under the Securities
Exchange Act of 1934, as amended (the "Exchange Act"). The address of the
principal executive office of the Issuer is One Possumtown Road, Piscataway, New
Jersey 08854.
Item 3. Source and Amount of Funds or Other Consideration.
-------------------------------------------------
On or about November 20, 2000, Andlinger Capital XXVI used funds
advanced by Mr. G. Andlinger and other members of Andlinger Capital XXVI to
exercise Investor A Warrants (as defined in the Original Statement) to purchase
1,000,000 shares of Common Stock at an exercise price of $1.00 per share.
Andlinger continues to hold Investor A Warrants, exercisable at $1.00 per share,
for 1,000,000 shares of Common Stock.
Item 4. Purpose of Transaction.
----------------------
The Reporting Persons have exercised Investor A Warrants and acquired
the underlying Common Stock for investment purposes. It is the Reporting
Persons' understanding that the Company has used a portion of the proceeds from
such exercise to pay the cash portion of the merger consideration paid by the
Company to the stockholders of PSI Holding Corporation ("PSI"), in connection
with the Company's acquisition of all of the issued and outstanding capital
stock of PSI and its wholly-owned subsidiaries, Protein Solutions, Inc. and
Protein Solutions Ltd. through the merger of PSI with and into a wholly-owned
subsidiary of the Company.
The Reporting Persons do not have any plans or proposals, other than
those described in this Item 4 and Item 6 of this Statement, which relate to or
would result in any of the actions or transactions specified in clauses (a)
through (j) of Item 4 of Schedule 13D. The Reporting Persons may from time to
time discuss among themselves and with other persons market conditions and other
factors concerning their interests in Andlinger Capital XXVI and its investment
in the Issuer, as well as specific actions that might be taken in light of
prevailing circumstances with respect to such interests. The Reporting Persons
reserve the right from time to time to acquire or dispose of the shares of the
Common Stock or the remaining Warrants (as defined in the Original Statement),
or to formulate other purposes, plans or proposals regarding the Issuer or the
Common Stock or the Warrants held by the Reporting Persons to the extent deemed
advisable in light of general investment policies, market conditions and other
factors.
Item 5. Interest in Securities of the Issuer.
------------------------------------
Based on the Issuer's Quarterly Report on Form 10-Q for the quarter
ended September 30, 2000, and information provided by the Issuer, there are
issued and outstanding 22,916,017 shares of Common Stock (including as
outstanding for such purpose the shares
<PAGE>
described in Item 3 of this Amendment and shares issued by the Company in
connection with the PSI acquisition, but not including as outstanding for such
purpose shares of Common Stock issuable upon exercise of the remaining
Warrants).
Andlinger Capital XXVI beneficially owns and has the shared power to
vote or direct the vote of, and shared power to dispose or direct the
disposition of, an aggregate of 16,606,000 shares of Common Stock (of which
5,000,000 shares are attributable to the remaining Warrants), representing
approximately 59.5% of the issued and outstanding shares of Common Stock
(including as outstanding for purposes of determining such percentage shares of
Common Stock issuable upon exercise of the remaining Warrants).
By virtue of Mr. G. Andlinger's relationship with Mr. Magida (as
described in Item 2 of this Statement) and as a controlling person of ACO, Mr.
G. Andlinger may be deemed to have shared power to dispose of or direct the
disposition of, and shared power to vote or direct the vote of, an aggregate of
16,606,000 shares of Common Stock (of which 5,000,000 shares are attributable to
the remaining Warrants), representing 59.5% of the issued and outstanding shares
of Common Stock (including as outstanding for purposes of determining such
percentage shares of Common Stock issuable upon exercise of the remaining
Warrants). Nothing in this Schedule 13D shall be deemed an admission that Mr. G.
Andlinger is the beneficial owner of the shares of Common Stock held by
Andlinger Capital XXVI.
Mr. Magida, as manager and as a member of Andlinger Capital XXVI, has
shared power to vote or direct the vote of, and shared power to dispose of or
direct the disposition of, an aggregate of 16,606,000 shares of Common Stock (of
which 5,000,000 shares are attributable to the remaining Warrants), representing
59.5% of the issued and outstanding shares of Common Stock (including as
outstanding for purposes of determining such percentage shares of Common Stock
issuable upon exercise of the remaining Warrants).
Messrs. Castello, Callaghan and M. Andlinger by virtue of their
relationships with the other Reporting Persons (as described in Item 2 of this
Statement) and as members of Andlinger Capital XXVI may be deemed to have shared
power to vote or direct the vote of, and shared power to dispose of or direct
the disposition of, an aggregate of 16,606,000 shares of Common Stock (of which
5,000,000 shares are attributable to the remaining Warrants), representing 59.5%
of the issued and outstanding shares of Common Stock (including as outstanding
for purposes of determining such percentage shares of Common Stock issuable upon
exercise of the remaining Warrants). Messrs. Castello, Callaghan and M.
Andlinger disclaim beneficial ownership of such shares.
Other than the transactions described in Item 3 of this Amendment, the
Reporting Persons have not acquired any shares of Common Stock during the past
60 days.
Item 7. Material To Be Filed as Exhibits
--------------------------------
Exhibit VII Power of Attorney, dated as of March 28, 2000, executed by
Andlinger Capital XXVI LLC Gerard R. Andlinger, Stephen A. Magida
and Merrick G. Andlinger and Mark F. Callaghan.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best knowledge and belief of the
Reporting Persons, the Reporting Persons certify that the information set forth
in this statement is true, complete and correct.
Date: November 22, 2000 ANDLINGER CAPITAL XXVI LLC
By: /s/ Stephen A. Magida
-------------------------
Name: Stephen A. Magida
Title: Manager
GERHARD R. ANDLINGER
***
-------------------------------
STEPHEN A. MAGIDA
/s/ Stephen A. Magida
-------------------------------
MERRICK G. ANDLINGER
***
-------------------------------
ROBERT M. CASTELLO
/s/ Robert M. Castello
-------------------------------
<PAGE>
MARK F. CALLAGHAN
/s/ Mark F. Callaghan
------------------------------
*** By: /s/ Stephen A. Magida
-----------------------
Stephen A. Magida
Attorney-in-Fact
Attention: Intentional misstatements or omissions of fact constitute
federal criminal violations (see 18 U.S.C. 1001)
